Obesity Temporarily Disrupts Liver’s Starvation Response Without Permanent Damage, Study Finds
Tokyo, Japan – A groundbreaking study from the University of Tokyo reveals that obesity causes temporary, but not permanent, disruptions in the…
Tokyo, Japan – A groundbreaking study from the University of Tokyo reveals that obesity causes temporary, but not permanent, disruptions in the…
Obesity isn’t just about weight—it’s a complex health condition with visible and hidden symptoms. Here are the most common signs your body…
In a proactive move to tackle rising health concerns among students, the Central Board of Secondary Education (CBSE) has directed…
Obesity isn’t just about weight—it’s a complex medical condition linked to serious health risks like diabetes, heart disease, and cancer. But…
The global obesity drug market is experiencing significant growth, with projections exceeding $150 billion annually in the coming decade. This…
Key Findings at a Glance The Study: How Weight-Loss Drugs Stack Up Against Surgery A landmark Israeli study (presented at the European Congress…
New SURMOUNT-5 Trial Results (2025) Key Takeaways ✅ Tirzepatide (Zepbound) led to significantly greater weight loss than semaglutide (Wegovy). Background: The…